![]() |
市場調查報告書
商品編碼
1348453
輸液幫浦的全球市場:規模,佔有率,趨勢分析(2024年~2030年):MedCoreInfusion Pump Market Size, Share & Trends Analysis | Global | 2024-2030 | MedCore | Includes: Large-Volume Infusion Pumps, Syringe Infusion Pumps, and 3 more |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2023年全球輸液幫浦市場規模預估為35億美元,較上年的34億美元成長3.1%。預測期內,該市場將繼續以 2.6% 的複合年增長率成長,預計最終將達到 42 億美元。全球輸液幫浦市場的現狀很大程度上取決於兩個主要參與者的存在:Becton Dickinson (BD) 和 B. Braun。
由於多種因素,全球輸液幫浦市場正在成長。造成這種增長的一個主要因素是老年人口的增加,這增加了醫療保健領域對輸液幫浦的需求。隨著老年人越來越依賴複雜的藥物治療,輸液幫浦已成為準確、安全地輸送藥物的重要工具。
老年患者可能面臨吞嚥困難和需要密切劑量控制等挑戰,但輸液幫浦實現的精確和受控給藥使他們受益匪淺。隨著老年人口的不斷擴大,滿足老年人獨特用藥需求的輸液幫浦仍然很重要,並有望在醫療保健支援中發揮越來越重要的作用。
2023年,Becton Dickinson (BD) 已成為全球輸液幫浦市場無可爭議的領導者。BD 對 CareFusion 的策略性收購,結合其廣泛的輸液治療產品線,鞏固了其在輸液幫浦領域的主導地位。具體來說,BD 的Alaris(R) 產品線包括:Alaris(TM) PC 單元、Alaris(TM) 泵浦模組、Alaris(TM) 注射器模組、Alaris(TM) PCA 模組、Alaris(TM) 自動ID 模組、 Alaris( TM) 它是一個模組化系統,包含 (TM) EtCO2 等關鍵模組,提供針對不同醫療保健環境的全面解決方案。
貝朗2023年穩居全球輸液幫浦市場第二位。該公司展現了對創新的堅定承諾,增強了其輸液幫浦產品線,特別注重軟體改進和節省空間的設計。B. Braun 的 Infusomat(R) 容積泵是全球公認的解決方案,並且已經存在相當長一段時間了,但他們的最新型號 Infusomat(R) Space 值得特別一提。這種緊湊、輕巧的設備設計為可堆疊,優化了空間利用率,並允許將多個泵浦有效地放置在有限的位置。
本報告提供全球輸液幫浦市場相關調查,提供市場概要,以及各市場區隔趨勢,市場分析與今後的預測等。
In 2023, the worldwide infusion pump market boasted a total worth of $3.5 billion, marking a 3.1% uptick from the previous year when it stood at $3.4 billion. Projections indicate a continued growth trajectory throughout the forecast period, with a compound annual growth rate (CAGR) of 2.6%, ultimately reaching an estimated value of $4.2 billion. Notably, the current landscape of the global infusion pump market is predominantly influenced by the presence of two key players, namely Becton Dickinson (BD) and B. Braun.
Our extensive medical market research efforts encompassed a comprehensive evaluation of more than 25 infusion pump companies spanning across all seven continents. Employing a rigorous methodology, we delved into various facets of the market, including market sizes, unit sales, company market shares, and generated precise forecasts. The complete report suite dedicated to the global infusion pump market encompasses a range of categories, including large-volume infusion pumps, syringe infusion pumps, patient-controlled analgesia (PCA) infusion pumps, electronic ambulatory infusion pumps, and disposable ambulatory infusion pumps.
The global infusion pump market is on an upward trajectory, driven by several factors. A significant contributor to this growth is the increasing elderly population, which has heightened the demand for infusion pumps in the realm of healthcare. As older individuals increasingly rely on complex medication regimens, infusion pumps have emerged as indispensable tools for ensuring the precise and safe delivery of pharmaceuticals.
Senior patients, who may face challenges such as difficulty swallowing or the need for meticulous dosage management, derive substantial benefits from the precise and controlled administration of medications facilitated by infusion pumps. As the demographic of elderly individuals continues to expand, the significance of infusion pumps in meeting their specific medication requirements remains paramount and is expected to play an increasingly critical role in healthcare assistance.
In the year 2023, Becton Dickinson (BD) emerged as the undisputed leader in the global infusion pump market. BD's strategic acquisition of CareFusion, coupled with its extensive IV therapy product line, firmly established its dominance in the IV infusion pump sector. Notably, BD's Alaris® product line distinguishes itself as a modular system encompassing vital modules such as the Alaris™ PC Unit, Alaris™ Pump Module, Alaris™ Syringe Module, Alaris™ PCA Module, Alaris™ Auto-ID Module, and Alaris™ EtCO2, providing comprehensive solutions tailored for diverse healthcare settings.
Close on its heels, B. Braun secured the second position in the global infusion pump market for the year 2023. The company showcased a strong commitment to innovation, enhancing its infusion pump product lines with a particular emphasis on software improvements and space-efficient designs. B. Braun's Infusomat® volumetric pump, a globally recognized solution, has been available for a significant duration, and its latest iteration, the Infusomat® Space, deserves special mention. This compact and lightweight device is designed for stackability, optimizing space utilization and enabling the efficient placement of multiple pumps in limited areas.
The remainder of the market share was distributed among various competitors, each focusing on specific segments, with only a handful competing across the entire spectrum. Companies like BD and B. Braun enjoy a distinctive advantage in this market due to their ability to offer a diverse range of infusion pumps, serving as comprehensive one-stop solutions for healthcare facilities seeking to expand their pump capabilities.